MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
2. Industry_Business Architects & Consolidators
Industry: By Region (Globally)
Industry: U.S.(United States)
*Industry: Texas
Neos Therapeutics (NASDAQ:NEOS)
Organization & Developments: Neos
Parents
Neos Therapeutics (NASDAQ:NEOS)
Children
2016: Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT™ (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
2017: Biotech Forum Daily Digest: Revisiting Neos Therapeutics
2017: VA_65--Neos Therapeutics Brands, LLC
2018: Neos Therapeutics: Cotempla Off To A Strong Start - Neos Therapeutics (NASDAQ:NEOS)
2018: Neos Therapeutics: The Road Ahead_seekingalpha.com
2019: A Tough Road Ahead For Neos Therapeutics_seekingalpha.com
2019: Neos Therapeutics: ADHD Franchise Needs To Return To Prescription Growth_seekingalpha.com
2019: Neos Therapeutics: Q3 Earnings Strengthens Investment Thesis_seekingalpha.com
Emerging ADHD concern
Neos is an oral drug delivery company for prescription, over-the-counter and veterinary products in a wide range of therapeutic areas.
Jumps
*Key People: Neos
Finance & Acquisitions: Neos